real-world safety data of rituximab among mexican patients with neuromyelitis optica spectrum disorders

被引：0
|
作者：
Thomas, Domingo Coutinho [1 ]
Lopez, Yazmin Martinez [1 ]
Villanueva, Homero Alcocer [1 ]
Lopez, Sarai Rivera [1 ]
Gonzalez, Jose Gonzalez [1 ]
Vazquez, Teresita Corona [1 ]
Rivas, Veronica [1 ]
Rivera, Jose De Jesus Flores [1 ]
机构：
[1] Natl Inst Neurol & Neurosurg, Neurol Dept Demyelinating Disorders Clin, Mexico City, Mexico
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1680/3027
引用
收藏
页码：1127 / 1127
页数：1
相关论文
共 50 条
  • [1] real-world efficacy data of rituximab in patients with neuromyelitis optica spectrum disorders
    Coutinho Thomas, Domingo
    Martinez Lopez, Yazmin
    Alcocer Villanueva, Homero
    Gonzalez Gonzalez, Jose
    Rivera Lopez, Sarai
    Corona Vazquez, Teresita
    Rivas, Veronica
    Flores Rivera, Jose
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1100 - 1100
  • [2] Real-world Safety Data of Rituximab among Mexican Patients with Neuromyelitis Optica AQP4-IgG serum positive from 2007 to 2024
    Coutinho Thomas, Domingo
    Gonzalez Perez, Karla
    Evangelista Osorio, Arath Amauri
    Martinez Lopez, Yazmin
    Rivas, Veronica
    Corona Vazquez, Teresita
    Flores Rivera, Jose de Jesus
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1118 - 1119
  • [3] The efficacy of rituximab in patients with neuromyelitis optica spectrum disorder: A real-world study from Turkey
    Uzunkopru, Cihat
    Tutuncu, Melih
    Gunduz, Tuncay
    Gumus, Haluk
    Sen, Sedat
    Demir, Serkan
    Cinar, Bilge Piri
    Ture, Hatice Sabiha
    Uygunoglu, Ugur
    Togrol, Rifat Erdem
    Terzi, Murat
    Kurtuncu, Murat
    Ozakbas, Serkan
    Tutuncu, Mesude
    Beckmann, Yesim
    Siva, Aksel
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (07)
  • [4] Retrospective Observation of Low-Dose Rituximab Treatment in Chinese Patients With Neuromyelitis Optica Spectrum Disorders in a Real-World Setting
    Xiao, Haibing
    Zeng, Wenshuang
    Li, Ling
    Li, Lina
    Cui, Yuzhen
    Wang, Jie
    Ye, Jinhao
    Yang, Qingyan
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [5] A real-world study on the utility of regular rituximab treatment for neuromyelitis optica spectrum disorder
    Chen, Xuefen
    Wang, Rui
    Li, Rui
    Hu, Shengfei
    Shi, Ziyan
    Zhou, Hongyu
    JOURNAL OF NEUROLOGY, 2025, 272 (03)
  • [6] Efficacy and safety of azathioprine for neuromyelitis optica spectrum disorders: A meta-analysis of real-world studies
    Luo, Daohuang
    Wei, Ran
    Tian, Xin
    Chen, Chaoyang
    Ma, Lingyun
    Li, Min
    Dong, Xiu
    Zhang, Enyao
    Zhou, Ying
    Cui, Yimin
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 46
  • [7] Real-world efficacy and Tolerability of Novel Monoclonal Antibodies and Rituximab for Neuromyelitis Optica Spectrum Disorder
    Javed, Zarmina
    Du, Mengke
    Cohen, Jeffrey
    Abbatemarco, Justin
    Rensel, Mary
    Ontaneda, Daniel
    Kunchok, Amy
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1208 - 1209
  • [8] Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in caucasian patients
    Radaelli, M.
    Sangalli, F.
    Moiola, L.
    Rodegher, M.
    Colombo, B.
    Esposito, F.
    Fazio, R.
    Martinelli, V.
    Comi, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 351 - 351
  • [9] Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patients
    Radaelli, M.
    Moiola, L.
    Sangalli, F.
    Esposito, F.
    Barcella, V.
    Ferre, L.
    Rodegher, M.
    Colombo, B.
    Fazio, R.
    Martinelli, V.
    Comi, G.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (04) : 511 - 519
  • [10] A meta-analysis on efficacy and safety of rituximab for neuromyelitis optica spectrum disorders
    Dong, Gu-Yi
    Meng, Yan-Hong
    Xiao, Xiang-Jian
    MEDICINE, 2022, 101 (36) : E30347
12345